Clinical Trial Update: A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating CJC-1134-PC injection in adults with Type 2 diabetes mellitus and inadequate glycemic control despite metformin therapy (wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CJC-1134-PC

Snippet

Sponsor: Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. | Conditions: Type 2 Diabetes Mellitus - Poor Control | Phase 3 | Status: COMPLETED